CVS Health (NYSE:CVS) added ~8% in the premarket on Thursday after the managed care giant exceeded Street forecasts with its ...

While competitors continue to struggle with healthcare costs, Aetna and CVS are celebrating an 8.4% increase in ...

CVS Health ’s CVS Pharmacy and Consumer Wellness (“PCW”) segment has seen steady growth in recent months, with revenues up 11.1% year over year in the first quarter of 2025.

The healthcare giant raised its full-year adjusted EPS guidance to a range of $6.30 to $6.40, up from its previous outlook of ...

CVS’s stock was having its best day in more than five months, amid strong growth in all of the company’s business units.

CVS CEO David Joyner pointed to strength in its retail pharmacy and improvement in its insurance unit, Aetna, which is ...

Aetna saw its medical benefits ratio increase months after CVS announced it would exit the ACA individual market due to struggling performance.

CVS Health beats on Q2 earnings and raises 2025 EPS outlook, lifting shares nearly 8% on strong segment growth and margin ...

CVS' Pharmacy & Consumer Wellness segment added $32.4B in revenue with ~12% YoY growth as prescriptions filled on a 30-day equivalent basis increased by ~6%, mainly due to higher utilization.

On Wednesday, CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total revenues increased 4.2%, driven by growth in the Health ...

Barclays upgrades CVS Health to Overweight, citing gains in pharmacy market share and potential upside from CostVantage. CVS is expected to recover 200 basis points in Medicare margins by 2026 ...

CVS Health ’s CVS Pharmacy and Consumer Wellness (“PCW”) segment has seen steady growth in recent months, with revenues up 11.1% year over year in the first quarter of 2025. Performance was supported ...